Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Apogee Therapeutics Inc (NASDAQ: APGE) closed the day trading at $40.91 down -0.34% from the previous closing price of $41.05. In other words, the price has decreased by -$0.34 from its previous closing price. On the day, 0.55 million shares were traded. APGE stock price reached its highest trading level at $41.03 during the session, while it also had its lowest trading level at $38.79.
Ratios:
For a better understanding of APGE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.39 and its Current Ratio is at 16.39. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on November 25, 2024, initiated with a Buy rating and assigned the stock a target price of $89.
On May 10, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $80.
On December 20, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $43.BTIG Research initiated its Buy rating on December 20, 2023, with a $43 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 08 ’25 when HENDERSON MICHAEL THOMAS sold 15,000 shares for $48.85 per share. The transaction valued at 732,693 led to the insider holds 1,309,487 shares of the business.
HENDERSON MICHAEL THOMAS bought 15,000 shares of APGE for $732,675 on Jan 08 ’25. On Jan 02 ’25, another insider, Dambkowski Carl, who serves as the Chief Medical Officer of the company, sold 4,085 shares for $46.94 each. As a result, the insider received 191,740 and left with 255,348 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APGE now has a Market Capitalization of 2335862784 and an Enterprise Value of 1879865984.
Stock Price History:
The Beta on a monthly basis for APGE is 2.39, which has changed by 0.26036227 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, APGE has reached a high of $72.29, while it has fallen to a 52-week low of $30.84. The 50-Day Moving Average of the stock is -16.06%, while the 200-Day Moving Average is calculated to be -16.91%.
Shares Statistics:
Over the past 3-months, APGE traded about 456.09K shares per day on average, while over the past 10 days, APGE traded about 434310 shares per day. A total of 45.02M shares are outstanding, with a floating share count of 36.30M. Insiders hold about 37.97% of the company’s shares, while institutions hold 80.63% stake in the company. Shares short for APGE as of 1734048000 were 7973039 with a Short Ratio of 17.73, compared to 1731628800 on 6623233. Therefore, it implies a Short% of Shares Outstanding of 7973039 and a Short% of Float of 20.62.
